产品详情
Targets
Target | Value |
---|---|
VEGFR2/KDR | IC50: 0.5nM |
c-Kit | IC50: 2nM |
VEGFR3/FLT4 | IC50: <=3nM |
VEGFR1/FLT1 | IC50: 5nM |
PDGFRβ | IC50: 5nM |
FGFR1 | IC50: 26nM |
PDGFRα | IC50: 36nM |
CSF-1R | IC50: 110nM |
Src | IC50: 130nM |
Abl | IC50: 260nM |
FLT3 | IC50: >1μM |
HER2/ErbB2 | IC50: >1μM |
CDK2 | IC50: >1μM |
CDK4 | IC50: >1μM |
EGFR | IC50: 1.6μM |
AuroraA | IC50: >10μM |
AuroraB | IC50: >10μM |
MEK | IC50: >10μM |
In vitro (25°C) | DMSO | 80 mg/mL (177.57 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 5% DMSO+50% PEG 300+5% Tween+ddH2O | 4 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 22.2 mL | 110.99 mL | 221.98 mL |
0.5 mM | 4.44 mL | 22.2 mL | 44.4 mL |
1 mM | 2.22 mL | 11.1 mL | 22.2 mL |
5 mM | 0.44 mL | 2.22 mL | 4.44 mL |
*The above data is based on the productmolecular weight 450.5 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10185 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 450.5 |
Formula | C25H27FN4O3 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 288383-20-0 |
Synonyms | Recentin |
SMILES | CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCC5 |
产品标签
Product Questions
Product Questions
Vatalanib (PTK787) 2HCl
Vatalanib (PTK787) 2HCl是一种小分子蛋白激酶抑制剂,可抑制抑制所有已知VEGF受体以及血小板衍生的生长因子…
(-)-Catechin gallate
(-)-Catechin gallate是绿茶的抗氧化成分。在uM浓度下,抑制VEGF诱导的酪氨酸磷酸化。
RAF265 (CHIR-265)
RAF265 (CHIR-265)是一种口服,高度选择性的RAF和VEGFR激酶抑制剂,可控制或正常化VEGFR-2,同时抑制B-raf和c-Raf…
CYC116 (CYC-116)
CYC116 (CYC-116)是一种有效的Aurora A/B抑制剂,Ki为8.0 nM/9.2 nM,对VEGFR2(Ki为44 nM)作用稍弱。
Linifanib (ABT-869)
Linifanib (ABT-869)是一种结构新颖的有效RTK,VEGF和PDGF抑制剂,对人内皮细胞,PDGFR-β,KDR和CSF-1R的IC50分别为0.…
ZM 323881 hydrochloride
ZM 323881 hydrochloride是一种有效且选择性的人血管内皮生长因子受体2(VEGFR2/KDR)激酶活性抑制剂。
BMS-817378
BMS-817378是Met/VEGFR-2双重抑制剂BMS-794833的新型前药。